Wordt geladen...
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
Migraine is considered a neurovascular disease affecting more than 10% of the general population. Currently available drugs for the acute treatment of migraine are vasoconstrictors, which have limitations in their therapeutic use. The calcitonin gene-related peptide (CGRP) has a key role in migraine...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002638/ https://ncbi.nlm.nih.gov/pubmed/21179597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285610388343 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|